Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Jul 01, 2005 by Edgar Snyder

ADHD Drug Labels Indicate Risks


Attention deficit hyperactivity disorder (ADHD) sufferers could be getting more than they bargained for from drugs prescribed to relieve their symptoms. The FDA ordered that labels on certain ADHD medications indicate a possibility of psychiatric side effects. A category of ADHD drugs that includes Concerta and Ritalin has caused reported hallucinations, suicidal thoughts and psychotic behavior as well as aggression and violent actions.

The FDA also plans to investigate the connection between cardiovascular concerns and ADHD drugs after some Concerta users reported hypertension, chest pain, arrhythmias and rapid heart beat.

In the U.S., roughly 7.8 million prescriptions were filled for Concerta. The FDA estimates about six million of those prescriptions were filled for people 16 years old and younger.

An FDA investigation into possible psychiatric side effects of competing ADHD drugs, such as amphetamines, which include Adderall and Strattera, is also planned.

For more information about dangerous drugs, visit the Recalled Drugs and Other Drug Alerts Legal Center.

Source: “FDA Offers More Details on Relabeling.” By Anna Wilde Mathews and Leila Abboud. The Wall Street Journal. June 30, 2005.
“New warnings due for ADHD drugs.” By Liz Szabo. USA Today. June 30, 2005.

Disclaimer: All drug-related litigation will involve co-counsel.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe
Sep 14, 2016
PA Residents: You're This Much More Likely to Hit a Deer